SCHEMBL6917834

SCHEMBL6917834

C/C(=N\c1c(C)cccc1C)c1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.47
PAX8 Q06710 2/20 0.47
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
TOP2A P11388 2/20 0.45
AGTR1 P30556 4/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 2/20 0.44
NAPRT Q6XQN6 1/20 0.44
P4HTM Q9NXG6 1/20 0.44
OPRK1 P41145 1/20 0.43
ALOX12 P18054 1/20 0.43
GFER P55789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589082 1.00 KDM4E (0.58) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL5693593 0.98 KDM4E (0.56) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL29733362 0.94 KDM4E (0.51) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL18896034 0.87 KDM4E (0.54) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL5588882 0.87 KDM4E (0.54) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL16096919 0.87 HKDC1 (0.48) KDM4EPAX8NPC1RAB9AAGTR1
SCHEMBL5589427 0.87 KDM4E (0.47) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL16471834 0.87 KDM4E (0.47) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL13350386 0.86 KDM4E (0.61) KDM4EALDH1A1PAX8NPC1RAB9A
SCHEMBL5693530 0.85 KDM4E (0.46) KDM4EALDH1A1PAX8NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981846-B1 Producing cyclic fuels from conjugated diene THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2021-04-20 US claimed
US-10981846-B1 Producing cyclic fuels from conjugated diene THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2021-04-20 US disclosed
US-10981846-B1 Producing cyclic fuels from conjugated diene THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2021-04-20 US disclosed
US-20040044149-A1 Cr complexes and their use for the polymerization of alpha-olefins SOLVAY POLYOLEFINS EUROPE-BELGIUM (BE) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981846-B1 Producing cyclic fuels from conjugated diene FDFT1, PC, NDUFS8 KDM4E 2761/4885ALDH1A1 900/4885PAX8 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.